Introducing Felbamate developed according to the Felbatol standard—a broad‑spectrum anticonvulsant that modulates NMDA receptor and GABA activity to control complex partial seizures. Reserved for refractory cases due to its potent efficacy, this formulation provides improved seizure suppression, enhanced neural stability, and better overall quality of life with targeted, effective tablet therapy.